Last modified by Wilton Risenhoover on 2022/07/06 01:17
From version < 25.2 >
edited by Md. Touhidul Islam
on 2021/09/19 05:40
To version < 26.1 >
edited by Md. Touhidul Islam
on 2021/09/30 09:17
< >
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -4,7 +4,7 @@
4 4  
5 5  = Summary =
6 6  
7 -* Square Pharmaceuticals Ltd (DSE: SQURPHARMA, CSE: SQURPHARMA) was established in 1958 as a partnership firm by Late Samson H. Chowdhury.
7 +* Square Pharmaceuticals Ltd was established in 1958 as a partnership firm by Late Samson H. Chowdhury.
8 8  * General public holds 36.25% of the total shares; sponsors, foreigners, and institutions hold 34.57%, 18.61%, and 10.57%, respectively. The company has an authorised capital of Tk 10,000 million and paid-up capital of Tk 8,864.51 million.
9 9  * The production units of the company are basically two types – primary, and secondary units.
10 10  * The company earn BDT 12.96 billion profit after tax (PAT) during the same year, a 22.66% growth year on year. Net asset value (NAV) stood at 69.85 million, a 14.87% increase year on year. Earnings per share of the company has grown 22.66% and stood at BDT 15.35 during the same year. The company paid cash dividend of BDT 3.97 billion during FY20.
... ... @@ -11,7 +11,7 @@
11 11  
12 12  = Company overview =
13 13  
14 -Square Pharmaceuticals, the flagship company of Square Group, is the largest pharmaceuticals company in Bangladesh. The company was established in 1958 as a partnership firm by Late Samson H. Chowdhury. It was incorporated as a private limited company in 1964. The company was converted to public limited company in 1991 and got listed in the stock exchanges in 1995. The company is holding the highest position in the industry since 1985 and it aspires to become a high-performance global player. The company started its exporting business in 1987 and now exports to more than 43 countries around the globe.{{footnote}}https://www.thedailystar.net/business/economy/news/square-pharma-set-launch-factory-kenya-2089101{{/footnote}} In financial year 2019-20, the company exports amounted to Tk 165 crore, an 11% increase year on year.
14 +Square Pharmaceuticals (DSE: SQURPHARMA, CSE: SQURPHARMA), the flagship company of Square Group, is the largest pharmaceuticals company in Bangladesh. The company was established in 1958 as a partnership firm by Late Samson H. Chowdhury. It was incorporated as a private limited company in 1964. The company was converted to public limited company in 1991 and got listed in the stock exchanges in 1995. The company is holding the highest position in the industry since 1985 and it aspires to become a high-performance global player. The company started its exporting business in 1987 and now exports to more than 43 countries around the globe.{{footnote}}https://www.thedailystar.net/business/economy/news/square-pharma-set-launch-factory-kenya-2089101{{/footnote}} In financial year 2019-20, the company exports amounted to Tk 165 crore, an 11% increase year on year.
15 15  
16 16  (% style="text-align:center" %)
17 17  [[image:journey of square.PNG||alt="journey of square pharmaceuticals" height="727" width="1183"]]
This site is funded and maintained by Fintel.io